XML | Respond to this article | Alert & updates | Request permissions | Email to a friend |
Background: 13-butoxyberberine bromide is a berberine derivative that has not been reported on the anti-migration mechanism of breast cancer. Cancer metastasis is the major cause of cancer mortality, about 90% of cancer patients death are caused by cancer metastasis not the primary tumor. Therefore, the compound that could inhibit cancer migration is necessary for development as anti-cancer drug.
Objective: To investigate the effects of 13-butoxyberberine bromide on the anti-migration of breast cancer MDA-MB-231 cells.
Materials and Methods: Cell viability was determined by MTT assay. Wound-healing assay and transwell chamber assay were used to determine cell migration. Protein expression levels were examined by western blot analysis.
Results: 13-Butoxyberberine bromide at sub-toxic concentration (10 µg/mL) inhibited cell migration in MDA-MB-231 treated cells via down-regulation of MMP-2 and MMP-9 expressionwhich play important role in cancer cell metastasis.
Conclusion: 13-Butoxyberberine bromide at 10 µg/mL showed anti-migration effect against MDA-MB-231 cells through inhibition of mediator proteins. These findings could be useful in the development of 13-butoxyberberine bromide to be a novel anti-migration agent for clinical use in the future.
Keywords: Breast cancer, 13-butoxyberberine bromide, Migration, MMPs